(Q69240392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

30 September 2019

main subject

1 reference

1 reference

L L Martens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

F F Rutten

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

D W Erkelens

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

C A Ascoop

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 October 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

30 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

4A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

54S-58S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980600-X

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980600-X

Efficacy and long-term adverse effect pattern of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980600-X

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980600-X

Improvement in long-term survival among patients hospitalized with acute myocardial infarction, 1970 to 1980. The Minnesota Heart Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980600-X

10.1016/S0002-9343(89)80600-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2508473%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference